Cero AI offers an automated communication platform for healthcare, facilitating task coordination between hospitals and patients via WhatsApp for appointment management.
Founded
2016
Revenue
$7.3M
Company Stage
Series A
Investors
- Y Combinator
- Crossbeam Venture Partners
YC Batch
S21
Product Features & Capabilities
Tumor cell clearance therapies, CER T-cell platform, engineered T cell therapeutics, targeting hematologic malignancies, targeting solid tumors, high yields of drug product, favorable memory and immunophenotypic profiles.